P2–107: Comparison between pure Alzheimer's disease and Alzheimer's disease with mild parkinsonian sign

Demographics Age, mean6SD, years 6168.8 63612.6 0.002 6168.8 6168.8 1 Male, n(%) 93 (31.7%) 347(54.9%) <0.001 93 (31.7%) 93 (31.7%) 1 Hypertension, n(%) 102 (34.8%) 390 (61.7%) <0.001 102(34.8%) 78 (26.6%) 0.03 Diabetes mellitus, n(%) 21 (7.2%) 132 (20.9%) <0.001 21 (7.2%) 31(10.6%) 0.19 Ischemic heart disease, n(%) 29 (9.9%) 33 (7.4%) 0.23 29 (9.9%) 12 (4.1%) 0.01 Atrial fibrillation,n(%) 2 (0.7%) 40 (6.3%) <0.001 2 (0.7%) 3 (1.0%) 0.65 Hyperlipidemia, n(%) 108 (36.9%) 177 (28%) 0.01 108(36.9%) 49 (17%) <0.001 BMI, mean6SD 24.264.0 25.1617.7 0.46 24.264.0 23.962.9 0.36 Previous ischemic stroke, n(%) 9 (3.1%) 122 (27.4%) <0.001 9 (3.1%) 2 (0.7%) 0.06 lipid lowering agent, n(%) 36/108 (33.3%) 93/177 (63.3%) 0.00 36/108 (33.3%) 25/49 (51.0%) 0.03 Laboratory findings Systolic BP, mm Hg 123613.5 152624.9 <0.001 123613.5 118614.9 0.009 Diastolic BP, mm Hg 71613.1 84615.3 <0.001 71613.1 70610.2 0.415 Total cholesterol>240mg/dl, n(%) 27/199 (13.6%) 33/484 (6.8%) 0.01 27/199 (13.6%) 39/268 (14.3%) 0.76 Triglycerides >200mg/dl, n(%) 7/108 (6.5%) 60/467 (14.0%) 0.06 7/108 (6.5%) 28/268 (10.4%) 0.23 LDL>130 mg/dl, n(%) 33/108 (30.6%) 123/467 (26.3%) 0.37 33/108 (30.6%) 93/268 (34.7%) 0.44 HDL<40 mg/dl, n(%) 13/108 (12.0%) 151/467 (32.3%) <0.001 13/108 (12.0%) 19/268 (7.1%) 0.12 HbA1c,mean6SD, % 5.660.48 5.861.71 0.10 5.660.48 5.960.86 <0.001